Export Snapshot

Minimum order

1 Centimetre

HSN Code

On request

Origin

India

Lead time

On request

Port of dispatch

On request

Packaging

Standard export packaging

Shelf life / storage

As per product specification

Export markets served

DZ AD AI AO AR +47 others

Ability to customise

As per OEM brief

Values shown are for Melizza Lifescience.

Company Melizza Lifescience

Melizza Lifescience

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Drugs & Pharmaceuticals.

View profile →

Established

Not shared

Employees

–

GST

24GQFPM5460R1Z4

IEC code

GQFPM5460R

Export markets

DZ AD AI AO AR +47 others

Member since

Aug 2025

Turnover

On request

Incorporation type

On request

Product details

Dosage & Administration:

• Typical dose: 1250 mg/m² orally twice daily for 14 days, followed by 7 days rest (21-day cycle).

• Dose adjustments are based on toxicity and patient condition.

• Tablets should be swallowed with water within 30 minutes after a meal.

(Only to be prescribed and supervised by an oncologist.)

Key Benefits:

• Oral chemotherapy – no hospitalization required.

• Tumor-targeted activation for better safety profile.

• Effective in multiple solid tumors including breast, colon, and gastric cancers.

Packaging:

• Box of 120 tablets (500 mg each)

• Also available in 150 mg strength (varies by brand/market)

Storage:

• Store below 25°C, in a dry place.

• Protect from light and moisture.

Important Notes:

• For oncology use only.

• Side effects may include hand-foot syndrome, diarrhea, nausea, fatigue.

• Dose modification required in renal impairment.

• Contraindicated in pregnancy and breastfeeding.

Oncology products supplier from India

Description provided by Melizza Lifescience.

Capecitabine 500 mg

Oncology / Antimetabolite Chemotherapy

Prodrug of 5-FU activated selectively in tumor cells, inhibits thymidylate synthase

Colorectal Cancer, Breast Cancer, Gastric Cancer

Oral tablet

1250 mg/m² twice daily for 14 days followed by 7 days rest

Box of 120 tablets, 500 mg each

Store below 25°C, dry place, protect from light and moisture

Hand-foot syndrome, diarrhea, nausea, fatigue

Nova

Specifications

Generic Name

Capecitabine

Brand Name

Capeta Nova

Strength

500 mg per tablet

Formulation

Tablet

Pack Size

120 tablets per box

Country of Origin

India

Therapeutic Use

Treatment of solid tumors including colorectal, breast, and gastric cancer

Contraindications

Pregnancy, breastfeeding, severe renal impairment

Prescription Requirement

Prescription only, supervised by an oncologist

Regulatory Status

Oncology pharmaceutical

Use cases

Category

Pharmaceuticals > Oncology Drugs > Chemotherapy Agents > Antimetabolites

Primary application

Brand

Not specified

Product type

Product

Logistics & handling

Lead time

On request

Packaging

As per buyer requirement

Storage condition

As recommended by supplier

Origin

India

Form

As listed by supplier

Commercials Melizza Lifescience

Minimum order

1 Centimetre

Lead time

On request

Payment terms

As per negotiated commercial agreement

Frequently asked by buyers

How does Capeta Nova 500mg reduce systemic toxicity compared to direct 5-FU therapy?

Capeta Nova 500mg is a prodrug that is enzymatically converted to 5-FU selectively within tumor tissues, limiting exposure of healthy cells to 5-FU and thus reducing systemic toxicity compared to direct administration of 5-FU.

What is the recommended dosing cycle for Capeta Nova 500mg in cancer treatment?

The typical dosing schedule is 1250 mg/m² taken orally twice daily for 14 days followed by a 7-day rest period, constituting a 21-day treatment cycle.

Can Capeta Nova 500mg be used in combination with other chemotherapy drugs?

Yes, Capeta Nova 500mg is often used both as monotherapy and in combination regimens with other chemotherapeutic agents to improve treatment outcomes in metastatic and advanced cancers.

What are key storage recommendations for maintaining Capeta Nova tablet efficacy?

Capeta Nova 500mg tablets should be stored below 25°C in a dry place, protected from light and moisture to maintain their stability and potency.

Is dose adjustment necessary for patients with renal impairment when using Capeta Nova 500mg?

Yes, patients with renal impairment require careful dose adjustments due to increased risk of toxicity when using Capeta Nova 500mg.

Question not answered? Sellers typically reply within 24–48 hours. Ask a question

What similar products are available in this category?

Browse all →

surbhi herbal tea - an ayurvedic formulation

Hetha

From $ 5.44

MOQ 1 Centimetre

brahmi ghrita nasal drop

Hetha

From $ 5.10

MOQ 1 Centimetre

himalayan badri gaumutra (gomutra) ark

Hetha

From $ 3.97

MOQ 1 Centimetre

triphala gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

desi cow gaumutra ark / gomutra ark

Hetha

From $ 3.40

MOQ 1 Centimetre

parijat aloevera gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

kachnar gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

tulsi giloy gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

More from Melizza Lifescience